BusPIRone Hydrochloride Tablets — Class II drug recall D-0602-2021
Completed recall by Oxford Pharmaceuticals, LLC, reported 2021-06-09, distributed nationwide. Presence of Foreign Tablets/Capsules
| Recall number | D-0602-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Oxford Pharmaceuticals, LLC, Birmingham, AL, United States |
| Recall initiated | 2021-05-05 |
| Classified | 2021-06-02 |
| Reported by FDA | 2021-06-09 |
| Distributed | Nationwide (US) |
| Quantity | 6,864 bottles |
| NDC | 69584-0091, 69584-0091-10, 69584-0091-50, 69584-0092, 69584-0092-10, 69584-0092-50, 69584-0093, 69584-0093-06, 69584-0093-10, 69584-0093-50, 69584-0094, 69584-0094-06, 69584-0094-18, 69584-0094-50 |
| Lot numbers | C21021A |
| Expiration dates | 2023-03 |
Product
BusPIRone Hydrochloride Tablets, USP, 15 mg, 100-count bottle, Rx only, Manufactured By: Oxford Pharmaceuticals, LLC Birmingham, Alabama 35211, NDC 69584-093-10
Reason for recall
Presence of Foreign Tablets/Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0602-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.